Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- MHRA guidance on Coronavirus (COVID-19)
- MHRA guidance on transition
- Drug and device alerts
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Marketing authorisations and licensing guidance
- Patient information leaflets and summaries of product characteristics
- Public assessment reports
- Medical devices regulation and safety
- Contact MHRA
- All MHRA services and information
Featured
Modified COVID-19 vaccines for variants to be fast-tracked, says MHRA and other regulators
Press release
Future vaccine modifications that respond to new variants of coronavirus to be made available quickly to UK recipients, without compromising on safety, quality or effectiveness.
Coronavirus (COVID-19) vaccine adverse reactions
Research and analysis
A weekly report covering adverse reactions to approved COVID-19 vaccines
The first COVID-19 vaccine for the UK, developed by Pfizer/BioNTech, has today been given approval for use following a thorough review carried out by the Medicines and Healthcare products Regulatory Agency (MHRA).
Guidance for industry and organisations to follow from 1 January 2021.
MHRA guidance on coronavirus (COVID-19)
Collection
We are producing guidance and information for industry, healthcare professionals and patients covering the coronavirus (COVID-19) outbreak.
The different types of tests and testing kits for COVID-19, and the specifications for manufacturers.
Latest from the Medicines and Healthcare products Regulatory Agency
What the Medicines and Healthcare products Regulatory Agency does
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Policy papers and consultations
- Lovima 75 microgram film-coated tablets (Desogestrel): Public Consultation
- Hana 75 microgram film-coated tablets (Desogestrel): Public Consultation
Transparency and freedom of information releases
See all transparency and freedom of information releasesOur management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Please get in touch with us by phone or email during the coronavirus (COVID-19) response period.
In line with the Government’s advice, our building at 10 South Colonnade closed at 5pm on Friday 27 March 2020.
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
MHRA
10 South Colonnade
London
E14 4PU
United Kingdom
During office hours:
020 3080 7651 (08:30 - 17:00)
Out of office hours:
07770 446 189 (17:00 - 08:30)
Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhragovuk
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
10 South Colonnade
London
E14 4PU
United Kingdom
Due to the COVID-19 pandemic we strongly encourage any requests to be made electronically to info@mhra.gov.uk.
Corporate information
Jobs and contracts